Moderna & Pfizer
15 shared events · Importance 4 · Last updated Sep 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Moderna: Moderna, a key player in mRNA vaccines, is likely to see increased investor confidence and market opportunities following the FDA's approval of an mRNA flu vaccine.
Pfizer: Pfizer, a leader in mRNA COVID-19 vaccines, benefits from the broader acceptance of mRNA technology, though the specific flu vaccine approval is not attributed to them.
Aug 06, 2026 · 6 articles
Domestic
Moderna: Received FDA approval for its mRNA flu vaccine mFlusiva, which showed 27% higher efficacy; expects doses in pharmacies soon, potentially boosting revenue.
Pfizer: Offers COVID-19 vaccines; benefits from continued recommendations and potential increased uptake.
Sep 02, 2026 · 20 articles
Regulatory
Moderna: Moderna received its fourth FDA-approved product and first mRNA flu vaccine, boosting its commercial prospects and validating its mRNA platform.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
Business
Moderna: Moderna secured a major supply contract with the International — European Commission for its RSV vaccine, enhancing its commercial prospects and competitive position against GSK and Pfizer.
Pfizer: Pfizer's RSV vaccine Abrysvo faces increased competition from Moderna's mRESVIA in the EU market.
Jul 09, 2026 · 6 articles
Tech
Moderna: Moderna is the co-developer of the vaccine and the primary beneficiary, with its stock more than doubling and market cap surging by nearly $40 billion. The trial success validates its mRNA platform and could lead to its entry into the cancer drug market, helping offset declining COVID-19 vaccine sales.
Pfizer: Pfizer, a partner of BioNTech, may benefit indirectly from the validation of mRNA technology in cancer treatment.
Aug 19, 2026 · 126 articles
Domestic
Moderna: One of the vaccine manufacturers; similar to Pfizer, minimal direct impact.
Pfizer: One of the vaccine manufacturers; the controversy may slightly affect public perception, but no direct impact.
Aug 06, 2026 · 17 articles
Business
Moderna: Moderna co-founder Robert S. Langer's involvement as an advisor links the company to Chiron, but Moderna itself is not directly affected.
Pfizer: Former Pfizer CMO Freda Lewis-Hall's advisory role provides a connection to Pfizer, but Pfizer itself is not directly affected.
Jul 22, 2026 · 6 articles
Tech
Moderna: Moderna is mentioned only because some Phase I participants had previously received Moderna COVID-19 mRNA vaccines, positioning it as a potential beneficiary of AdJane's mucosal booster concept. The event has no material effect on Moderna's business or outlook.
Pfizer: Pfizer is mentioned only because some Phase I participants had previously received Pfizer COVID-19 mRNA vaccines, making it a potential target for AdJane's complementary mucosal booster approach. The event has no material effect on Pfizer's business or outlook.
Sep 10, 2026 · 9 articles
Business
Moderna: Moderna is a partner with Vertex in developing CF treatments for patients not covered by Vertex's CFTR modulators. The acquisition does not directly affect Moderna.
Pfizer: Competitor in acromegaly market; PALSONIFY may compete with its treatments.
Jul 06, 2026 · 34 articles
Business
Moderna: Moderna is mentioned as an existing AWS customer, but this event does not directly impact it.
Pfizer: Pfizer is mentioned as an existing AWS customer, but this event does not directly impact it.
Aug 10, 2026 · 7 articles
Regulatory
Moderna: Moderna is another pharmaceutical company that entered into advance purchase agreements with the International — European Commission, also mentioned in the context of the secret vaccine deals.
Jun 11, 2026 · 7 articles
Domestic
Moderna: Moderna is named as a donor to Vaccinate Your Family, indicating its financial support for pro-vaccine advocacy, which indirectly benefits its vaccine business.
May 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Moderna and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard